Next Article in Journal
Antioxidant and Antiradical Activities of Manihot esculenta Crantz (Euphorbiaceae) Leaves and Other Selected Tropical Green Vegetables Investigated on Lipoperoxidation and Phorbol-12-myristate-13-acetate (PMA) Activated Monocytes
Next Article in Special Issue
Hydroxytyrosol Protects against Oxidative DNA Damage in Human Breast Cells
Previous Article in Journal
Effects of Dietary Glutamine Supplementation on the Body Composition and Protein Status of Early-Weaned Mice Inoculated with Mycobacterium bovis Bacillus Calmette-Guerin
Article Menu

Export Article

Open AccessArticle
Nutrients 2011, 3(9), 805-817; doi:10.3390/nu3090805

Deficiency in the 15 kDa Selenoprotein Inhibits Human Colon Cancer Cell Growth

Cancer Prevention Fellowship Program, National Cancer Institute, Rockville, MD 20892, USA
Molecular Biology of Selenium Section, Laboratory of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
Nutritional Science Research Group, National Cancer Institute, Rockville, MD 20892, USA
Department of Biological Sciences, Towson University, Towson, MD 21252, USA
Author to whom correspondence should be addressed.
Received: 1 August 2011 / Revised: 15 August 2011 / Accepted: 29 August 2011 / Published: 5 September 2011
(This article belongs to the Special Issue Diet and Cancer Prevention)
View Full-Text   |   Download PDF [572 KB, uploaded 5 September 2011]   |  


Selenium is an essential micronutrient for humans and animals, and is thought to provide protection against some forms of cancer. These protective effects appear to be mediated, at least in part, through selenium-containing proteins (selenoproteins). Recent studies in a mouse colon cancer cell line have shown that the 15 kDa selenoprotein (Sep15) may also play a role in promoting colon cancer. The current study investigated whether the effects of reversing the cancer phenotype observed when Sep15 was removed in mouse colon cancer cells, were recapitulated in HCT116 and HT29 human colorectal carcinoma cells. Targeted down-regulation of Sep15 using RNAi technology in these human colon cancer cell lines resulted in similarly decreased growth under anchorage-dependent and anchorage-independent conditions. However, the magnitude of reduction in cell growth was much less than in the mouse colon cancer cell line investigated previously. Furthermore, changes in cell cycle distribution were observed, indicating a delayed release of Sep15 deficient cells from the G0/G1 phase after synchronization. The potential mechanism by which human colon cancer cells lacking Sep15 revert their cancer phenotype will need to be explored further.
Keywords: HCT116 cells; HT29 cells; shRNA; selenium; cancer prevention HCT116 cells; HT29 cells; shRNA; selenium; cancer prevention
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Tsuji, P.A.; Naranjo-Suarez, S.; Carlson, B.A.; Tobe, R.; Yoo, M.-H.; Davis, C.D. Deficiency in the 15 kDa Selenoprotein Inhibits Human Colon Cancer Cell Growth. Nutrients 2011, 3, 805-817.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top